MyFinsight
Home
Blog
About
Investments
$571,995K
(368.73%↑ Y/Y)
Cash and cash
equivalents
$182,049K
(292.74%↑ Y/Y)
Prepaid clinical trial
costs
$12,996K
Other current assets
$8,801K
(-40.20%↓ Y/Y)
Total current assets
$775,841K
(323.72%↑ Y/Y)
Intangible assets, net
$50,000K
Operating lease
right-of-use assets
$1,107K
(745.04%↑ Y/Y)
Other non-current
assets
$661K
Property and equipment,
net
$611K
(71.15%↑ Y/Y)
Total assets
$828,220K
(351.12%↑ Y/Y)
Accumulated deficit
-$580,602K
(-63.96%↓ Y/Y)
Total liabilities and
stockholders' equity...
$828,220K
(351.12%↑ Y/Y)
Total stockholders'
equity (deficit)
-$12,781K
(-128.80%↓ Y/Y)
Additional paid-in capital
$567,772K
(42.49%↑ Y/Y)
Common stock, 0.001 par
value 95,000,000...
$49K
(25.64%↑ Y/Y)
Total liabilities
$841,001K
(504.09%↑ Y/Y)
Convertible notes
$753,235K
Total current
liabilities
$86,873K
(117.50%↑ Y/Y)
Operating lease
liabilities, non-current
$893K
Accrued license
milestone
$50,000K
Other accrued
expenses
$20,581K
Accounts payable
$8,093K
(-27.47%↓ Y/Y)
Accrued clinical trial
costs
$7,942K
Operating lease
liabilities, current
$257K
(84.89%↑ Y/Y)
Back
Back
Balance Sheet
Celcuity Inc. (CELC)
Celcuity Inc. (CELC)
source: myfinsight.com